» Articles » PMID: 29866653

Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2018 Jun 6
PMID 29866653
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Adenomatous polyposis coli (APC) is a key molecule to maintain cellular homeostasis in colonic epithelium by regulating cell-cell adhesion, cell polarity, and cell migration through activating the APC-stimulated guanine nucleotide-exchange factor (Asef). The APC-activated Asef stimulates the small GTPase, which leads to decreased cell-cell adherence and cell polarity, and enhanced cell migration. In colorectal cancers, while truncated APC constitutively activates Asef and promotes cancer initiation and progression, regulation of Asef by full-length APC is still unclear. Here, we report the autoinhibition mechanism of full-length APC. We found that the armadillo repeats in full-length APC interact with the APC residues 1362 to 1540 (APC-2,3 repeats), and this interaction competes off and inhibits Asef. Deletion of APC-2,3 repeats permits Asef interactions leading to downstream signaling events, including the induction of Golgi fragmentation through the activation of the Asef-ROCK-MLC2. Truncated APC also disrupts protein trafficking and cholesterol homeostasis by inhibition of SREBP2 activity in a Golgi fragmentation-dependent manner. Our study thus uncovers the autoinhibition mechanism of full-length APC and a novel gain of function of truncated APC in regulating Golgi structure, as well as cholesterol homeostasis, which provides a potential target for pharmaceutical intervention against colon cancers.

Citing Articles

The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer.

Wong C, Wu J, Ji F, Kang W, Bian X, Chen H Nat Commun. 2022; 13(1):3971.

PMID: 35803966 PMC: 9270407. DOI: 10.1038/s41467-022-31663-z.


Adenomatous Polyposis Coli (APC) in cell migration.

Fang X, Svitkina T Eur J Cell Biol. 2022; 101(3):151228.

PMID: 35483122 PMC: 9357102. DOI: 10.1016/j.ejcb.2022.151228.


A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway.

Peng L, Zhao M, Liu T, Chen J, Gao P, Chen L Cell Death Dis. 2022; 13(4):395.

PMID: 35459861 PMC: 9033806. DOI: 10.1038/s41419-022-04844-3.


DIscBIO: A User-Friendly Pipeline for Biomarker Discovery in Single-Cell Transcriptomics.

Ghannoum S, Leoncio Netto W, Fantini D, Ragan-Kelley B, Parizadeh A, Jonasson E Int J Mol Sci. 2021; 22(3).

PMID: 33573289 PMC: 7866810. DOI: 10.3390/ijms22031399.


Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC).

Wang W, Zhang L, Morlock L, Williams N, Shay J, De Brabander J J Med Chem. 2019; 62(10):5217-5241.

PMID: 31070915 PMC: 7252524. DOI: 10.1021/acs.jmedchem.9b00532.

References
1.
Xing Y, Clements W, Kimelman D, Xu W . Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev. 2003; 17(22):2753-64. PMC: 280624. DOI: 10.1101/gad.1142603. View

2.
Kawasaki Y, Senda T, ISHIDATE T, Koyama R, Morishita T, Iwayama Y . Asef, a link between the tumor suppressor APC and G-protein signaling. Science. 2000; 289(5482):1194-7. DOI: 10.1126/science.289.5482.1194. View

3.
Bienz M, Clevers H . Linking colorectal cancer to Wnt signaling. Cell. 2000; 103(2):311-20. DOI: 10.1016/s0092-8674(00)00122-7. View

4.
Petrosyan A . Onco-Golgi: Is Fragmentation a Gate to Cancer Progression?. Biochem Mol Biol J. 2016; 1(1). PMC: 4824322. DOI: 10.21767/2471-8084.100006. View

5.
Shiina N, Tsukita S . Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J Cell Biol. 2000; 148(3):505-18. PMC: 2174811. DOI: 10.1083/jcb.148.3.505. View